S01ED51 • latanoprost + timolol • Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents
The combination of latanoprost and timolol is used for the treatment of open-angle glaucoma and ocular hypertension in patients who do not respond adequately to monotherapy. Latanoprost increases the outflow of aqueous humor, while timolol reduces its production.
The medication is administered as eye drops, usually once daily in the evening. It is important to follow the doctor's instructions to ensure treatment efficacy.
Side effects may include eye irritation, redness, changes in iris color, or dry eyes. In rare cases, allergic reactions, bradycardia, or macular edema may occur.
This combination is not recommended for patients with bronchial asthma, severe heart failure, or hypersensitivity to any of the components.
Substance: latanoprost + timolol
Date of last drug list: 01-08-2023
Commercial code: W65048001
Concentration: 50mcg / 5mg / ml
Pharmaceutical form: ophthalmic solution
Quantity: 1
Product type: original
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.
Manufacturer: PFIZER MANUFACTURING BELGIUM N.V. - BELGIA
Holder: PFIZER EUROPE MA EEIG - BELGIA
Number: 7421/2015/01
Shelf life: 2 years-after packing for marketing;28 days-after the first opening of the bottle